Last reviewed · How we verify
Cost-Free Pharmacotherapy Group
Cost-Free Pharmacotherapy Group is a behavioral intervention that helps patients manage their medication adherence.
Cost-Free Pharmacotherapy Group is a behavioral intervention that helps patients manage their medication adherence. Used for Atrial fibrillation for stroke prevention, Heart failure management.
At a glance
| Generic name | Cost-Free Pharmacotherapy Group |
|---|---|
| Also known as | Nicotine Patch, Champix, Chantix, Wellbutrin |
| Sponsor | Ottawa Heart Institute Research Corporation |
| Modality | Small molecule |
| Therapeutic area | Behavioral Health |
| Phase | FDA-approved |
Mechanism of action
This program involves a combination of education, support, and reminders to encourage patients to take their medications as prescribed. By addressing the root causes of non-adherence, such as lack of knowledge or forgetfulness, patients are more likely to stick to their treatment plans and achieve better health outcomes.
Approved indications
- Atrial fibrillation for stroke prevention
- Heart failure management
Common side effects
- None reported
Key clinical trials
- RCT for Latina Mental Health Using Web-Based Apps (NA)
- Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer (NA)
- (COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies
- Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy (PHASE2)
- Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease (PHASE4)
- Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
- DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes (NA)
- Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: